Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with refractory colorectal cancer that express the epidermal growth factor receptor. - Saltz,L.B.; Meropol,N.J.; Loehrer,P.J.; Needle,M.N.; Kopit,J.; Mayer,R.J. (J Clin Oncol, 2004)